Boston Common Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,738
Closed -$6.12M 303
2025
Q2
$6.12M Sell
15,738
-4,567
-22% -$1.84M 0.17% 166
2025
Q1
$8.83M Buy
20,305
+3,579
+21% +$1.44M 0.27% 131
2024
Q4
$6.17M Buy
16,726
+4,637
+38% +$1.94M 0.18% 158
2024
Q3
$6.29M Buy
+12,089
New +$6.46M 0.16% 166
2023
Q1
Sell
-856
Closed -$439K 316
2022
Q4
$439K Buy
856
+17
+2% +$8.63K 0.02% 209
2022
Q3
$381K Buy
839
+344
+69% +$165K 0.02% 218
2022
Q2
$239K Sell
495
-266
-35% -$132K 0.01% 250
2022
Q1
$374K Sell
761
-92
-11% -$42.1K 0.02% 228
2021
Q4
$395K Buy
853
+42
+5% +$17.7K 0.02% 222
2021
Q3
$302K Buy
811
+2
+0.2% +$760 0.01% 228
2021
Q2
$309K Buy
809
+55
+7% +$21K 0.01% 230
2021
Q1
$271K Sell
754
-3
-0.4% -$965 0.02% 232
2020
Q4
$243K Buy
+757
New +$232K 0.02% 226

Other funds holding ELV

Boston Common Asset Management's ELV Position: Q3 2025 in Review

Boston Common Asset Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 15,738 shares — an estimated $6.12M sold.

Boston Common Asset Management first reported a position in ELV in Q4 2020 and held it in 13 quarters. The position peaked at $8.83M in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Boston Common Asset Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Boston Common Asset Management sold 15,738 Elevance Health shares in Q3 2025, an estimated $6.12M.
  • Boston Common Asset Management first reported a position in Elevance Health in Q4 2020 and held it in 13 quarters.
  • Boston Common Asset Management's Elevance Health position peaked at $8.83M in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Boston Common Asset Management's 13F filing for Q3 2025, filed 30 Oct 2025.